VRCA position history
The shares of Verrica Pharmaceuticals (VRCA) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 173,451 shares, $1.4M, 0.33% of portfolio, New
- 2026 Q1: 153,712 shares, $813K, 0.18% of portfolio, Reduce −11.4%
- 2026 Q2: 23,750 shares, $145K, 0.03% of portfolio, Reduce −84.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|